Consecutive publication list on the project and/or work referring to the project (in descending order)

16. Von Krogh A-S, Quist-Paulsen P, Waage A, Langseth ØO, Thorstensen K, Brudevold R, Tjønnfjord GE, Largiadèr CR, Lämmle B, Kremer Hovinga JA. High prevalence of hereditary thrombotic thrombocytopenic purpura in Central Norway: from clinical observation to evidence.

15. Von Krogh A-S, Kremer Hovinga JA, Romundstad PR, Roten LT, Lämmle B, Waage A, Quist-Paulsen P. ADAMTS13 gene variants and function in women with preeclampsia: a population-based nested case-control study from the HUNT study.

14. Von Auer C, von Krogh A-S, Kremer Hovinga JA, Lämmle B. Current insights into thrombotic microangiopathies: Thrombotic thrombocytopenic purpura and pregnancy.

Thromb Res 2015; 135 (Suppl. 1):S30–S33

13. Raval JS, Padmanabhan A, Kremer Hovinga JA, Kiss JE. Development of a clinically significant ADAMTS13 inhibitor in a patient with hereditary thrombotic thrombocytopenic purpura.
Am J Hematol 2015;90:E22

12. Falter T, Kremer Hovinga JA, Lackner K, Füllemann H-G, Lämmle B, Scharrer I. Late onset and pregnancy-induced congenital thrombotic thrombocytopenic purpura.
Haemostaseologie 2014;34:244–24

11. Von Krogh A-S, Kremer Hovinga JA, Tjønnfjord GE, Ringen IM, Lämmle B, Waage A, Quist-Paulsen P. The impact of congenital thrombotic thrombocytopenic purpura on pregnancy complications.
Thromb Haemost 2014;111:1180–1183

10. Knöbl P. Inherited and acquired thrombotic thrombocytopenic purpura (TTP) in adults.
Semin Thromb Hemost. 2014;40:493-502

9. Bennett M, Chubar Y, Gavish I, Aviv A, Stemer G, Chap-Marshak D. Experiences in a Family With the Upshaw-Schulman Syndrome Over a 44-Year Period.
Clin Appl Thromb Hemost. 2014;20:296-303

8. Rank CU, Kremer Hovinga JA, Taleghani MM, Lämmle B, Gøtze JP, Nielsen OJ. Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS13 gene.
Eur J Haematol. 2014;92:168-71

7. Knöbl PN. Treatment of thrombotic microangiopathy with a focus on new treatment options.
Haemostaseologie 2013;33:149-59

6. Kentouche K, Voigt A, Schleussner E, Schneppenheim R, Budde U, Beck JF, Stefańska-Windyga E, Windyga J. Pregnancy in Upshaw-Schulman syndrome.
Haemostaseologie 2013 May 29;33:144-8

5. Mansouri Taleghani M, von Krogh A-S, Fujimura Y, George JN, Hrachovinova I, Knöbl PN, Quist-Paulsen P, Schneppenheim R, Lämmle B, Kremer Hovinga JA. Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman syndrome) and the hereditary TTP registry.

Haemostaseologie 2013;33:138–143

4. Deal T, Kremer Hovinga JA, Marques MB, Adamski J. Novel ADAMTS13 Mutations in an Obstetric Patient with Upshaw-Schulman Syndrome.
J Clin Apher 2013;28:311-16

3. Kremer Hovinga JA, Lämmle B. ADAMTS13: Its role in pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura.
Hematology Am Soc Hematol Educ Program 2012;2012:610-616

2. George JN. Forecasting the future for patients with hereditary TTP.
Blood 2012;120:243-244 (Editorial)

1. Kremer Hovinga JA, Voorberg J. Improving on nature, re-designing ADAMTS13.
Blood 2012;119:3654-3655 (Editorial)